Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS - Monotropa_MS2 Analysis for Molecular Networking

ABSTRACT: Untargeted LC-MS profiling of M. uniflora in the positive and negative modes for MS2 molecular networking and annotation.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Monotropa Uniflora (ncbitaxon:50148)

SUBMITTER: Josh Kellogg

PROVIDER: MSV000095135 | GNPS | Mon Jun 24 13:54:00 BST 2024

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Monotropa_MS2 Analysis for Molecular Networking

Project description:Untargeted LC-MS profiling of M. uniflora in the positive and negative modes for MS2 molecular networking and annotation.

2024-06-24 | MSV000095135 | MassIVE

Enhanced Structure-Guided Molecular Networking (E-SGMN)-data

Project description:In this study, an enhanced structure-guided molecular networking (E-SGMN) method was used, which is specifically tailored for the Orbitrap Astral mass spectrometer. Reverse phase liquid chromatography (RPLC) analysis. ACQUITY BEH C8 column (100 mm×2.1 mm, 1.7 ?m, Waters, Milford, MA, USA) was used for the LC system in positive (ESI+) ionization modes, respectively. The temperature was set to 50°C, and the gradient elution flow rate was set at 0.35 mL/min. The mobile phase consisted of water (A) and acetonitrile with 0.1% formic acid (B) in ESI+ ionization mode. The initial gradient started with 5% B for 1 min, followed by a linear increase to 100% B within 23 min, and then maintained for an additional 4 min. Finally, the gradient was reduced to 5% B for system equilibration. Astral MS analysis. Mass spectrometry was performed on Orbitrap Astral (Thermo Fisher Scientific, Rockford, IL, USA) in full scan MS/ddMS2 mode. For the full scan properties of the Orbitrap detector, the MS1 scan range was 85-1250 m/z. Orbitrap resolution was 120,000. RF lens was set as 50%. Full-scan orbitrap MS1 was performed in parallel with fast and sensitive DDA MS2 (top 30) on the Astral mass analyzer, with an MS/MS acquisition rate of 150 Hz. The isolation window was 1 m/z. Normalized collision energy type was used in our work, and the HCD collision energy was set as 15%, 30%, 45% and 80%, respectively. The MS2 scan range was 50-1250 m/z. The normalized AGC target and injection time were 10% and 5 ms, respectively. The spray voltages were 3.5 kV and 3.0 kV in positive and negative ionization modes, respectively. The aux gas heater temperature and capillary temperature were 350°C and 320°C, respectively. The sheath gas and aux gas were 45 and 10 (in arbitrary units), respectively.

2025-03-23 | MSV000097411 | MassIVE

molecular networking of Trillium tschonoskii.

Project description:This is a dataset used for the orchestration of molecular networking which led the discovery of polyacetylated 18-norspirostanol saponins from Trillium tschonoskii.

| MSV000084268 | MassIVE

Molecular networking coupled to high-resolution mass spectrometry fragmentation reveals a multitude of urinary antihypertensive drug metabolites

Project description:Mass spectrometry is the current technique of choice in studying drug metabolism. High-resolution mass spectrometry (HR-MS) in combination with fragment analysis (MS/MS) has the potential to contribute to rapid advances in this field. However, the data emerging from such fragmentation spectra pose challenges to downstream analysis, given their complexity and size. Here we apply a molecular networking approach to seek drugs and their metabolites, in fragmentation spectra from urine derived from a cohort of 26 patients on antihypertensive therapy. In total, 165 separate drug metabolites were found and structurally annotated (17 by spectral matching and 122 by classification based on a clustered fragmentation pattern). The clusters could be traced to 13 drugs including the known antihypertensives verapamil, losartan and amlopidine. The molecular networking approach also generated networks of endogenous metabolites, including carnitine derivatives, and conjugates containing glutamine, glutamate and trigonelline. The approach offers unprecedented capability in the untargeted identification of drugs and their metabolites at the population level and has great potential to contribute to understanding stratified responses to drugs where differences in drug metabolism may determine treatment outcome. Keywords: Antihypertensive drugs, Drug metabolism, Fragmentation, High-resolution mass spectrometry, Metabolomics, Urine.

2016-05-23 | MTBLS307 | MetaboLights

Bioactive Molecular Networking for Mapping the Antimicrobial Constituents of the Baltic Brown Alga Fucus vesiculosus

Project description:mgf files, quantification tables and metadata files used in the publication Buedenbender et al., "Bioactive Molecular Networking for Mapping the Antimicrobial Constituents of the Baltic Brown Alga Fucus vesiculosus", Marine Drugs, 2020

2020-06-02 | MSV000085539 | MassIVE

GNPS - MIMB Feature Based Molecular Networking for Metabolite Annotation Sample Data

Project description:Example dataset for Methods in Molecular Biology Chapter - Feature Based Molecular Networking for Metabolite Annotation. This dataset includes the LC-MS/MS raw data (Bruker .d file format and centroided mzXML file format), metadata table used for the ste-by-step instructions, a batch file for MZmine2 data processing, and all resulting files from the MZmine2 and GNPS processing.

2019-02-28 | MSV000083500 | GNPS

MS2-affinity purification coupled with RNA sequencing (MAPS) reveals RybB sRNA targetome

Project description:Despite the overwhelming information about sRNAs, one of the biggest challenges in the sRNA field is characterizing sRNA targetomes. Thus, we develop a novel method to identify RNAs that interact with a specific sRNA, regardless of the type of regulation (positive or negative) or targets (mRNA, tRNA, sRNA). This method is called MAPS: MS2 affinity purification coupled with RNA sequencing. As proof of principle, we identified RNAs bound to RybB, a well-characterized E. coli sRNA. Identification of RNAs co-purified with MS2-RybB in a rne131 ΔrybB strain. RybB (without MS2) was used as control

2015-04-16 | E-GEOD-66518 | biostudies-arrayexpress

MS2-affinity purification coupled with RNA sequencing (MAPS) reveals RyhB sRNA targetome

Project description:Despite the overwhelming information about sRNAs, one of the biggest challenges in the sRNA field is characterizing sRNA targetomes. Thus, we develop a novel method to identify RNAs that interact with a specific sRNA, regardless of the type of regulation (positive or negative) or targets (mRNA, tRNA, sRNA). This method is called MAPS: MS2 affinity purification coupled with RNA sequencing. As proof of principle, we identified RNAs bound to RyhB, a well-characterized E. coli sRNA. Identification of RNAs co-purified with MS2-RyhB in a rne131 ?ryhB strain. RyhB (without MS2) was used as control

2015-04-16 | E-GEOD-66519 | biostudies-arrayexpress

Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer

Project description:This study intends to explore the clinicopathological characteristics and survival prognosis of locally recurrent colorectal cancer patients with different treatment modes by retrospectively analyzing the medical records of locally recurrent colorectal cancer patients who received hospitalization in our center. Transcriptome sequencing and public databases were used to screen for molecular markers related to locally recurrent colorectal cancer and to explore molecular markers’ regulatory role in the progression of locally recurrent colorectal cancer.

| 116635 | ecrin-mdr-crc

Global transcriptional responses to KI-MS2-008 treatment and Myc inactivation via doxycycline addition

Project description:The Myc/Max heterodimer has crucial roles in normal cellular processes such as cell proliferation, metabolism, apoptosis, and differentiation, but its activity is often deregulated in a majority of human cancers. In an effort to explore alternative modes of Myc perturbation, we identified KI-MS2-008 as a small molecule that binds Max and modulates Myc-driven transcription, and in some cellular contexts, KI-MS2-008 treatment leads to a decrease in c-Myc protein levels. As the Myc/Max heterodimer controls many cellular processes, we expected that treatment with this small molecule would cause changes in the transcriptome. We found that treatment with 10 µM KI-MS2-008 resulted in global alterations in the transcriptome, mimicking direct Myc inactivation with doxycycline in P493-6, a B cell line with a Tet-Off system for c-Myc expression. We also discovered enrichment of various Myc target gene sets in the genes downregulated in response to KI-MS2-008 treatment in P493-6 cells. This trend was also observed in ST486 cells, but not in P3HR1 cells, which were chosen as non-engineered B cell lines that were sensitive and insensitive, respectively, toward KI-MS2-008 in cell viability assays.

2019-03-14 | GSE107222 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data